Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dimer of Gag-Pol polyprotein [489-587] (Human immunodeficiency virus type 1) | BDBM719 ((4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Patents Similars | Article PubMed | 0.00230 | -69.1 | n/a | n/a | n/a | n/a | n/a | 6.2 | 37 |
National Cancer Institute | Assay Description Inhibition constants were determined by a fluorometric assay with the fluorogenic substrate Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Lys(DABCYL)-Ar... | Antimicrob Agents Chemother 37: 810-7 (1993) Article DOI: 10.1128/aac.37.4.810 BindingDB Entry DOI: 10.7270/Q2KH0KHT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dimer of Gag-Pol polyprotein [489-587] (Human immunodeficiency virus type 1) | BDBM579 ((4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | 0.00550 | -66.9 | n/a | n/a | n/a | n/a | n/a | 6.2 | 37 |
National Cancer Institute | Assay Description Inhibition constants were determined by a fluorometric assay with the fluorogenic substrate Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Lys(DABCYL)-Ar... | Antimicrob Agents Chemother 37: 810-7 (1993) Article DOI: 10.1128/aac.37.4.810 BindingDB Entry DOI: 10.7270/Q2KH0KHT | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Dimer of Gag-Pol polyprotein [489-587] (Human immunodeficiency virus type 1) | BDBM793 ((2S)-N-[(2S,3S)-4-[(4R)-4-(tert-butylcarbamoyl)-5,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | 0.00680 | -66.3 | n/a | n/a | n/a | n/a | n/a | 6.2 | 37 |
National Cancer Institute | Assay Description Inhibition constants were determined by a fluorometric assay with the fluorogenic substrate Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Lys(DABCYL)-Ar... | Antimicrob Agents Chemother 37: 810-7 (1993) Article DOI: 10.1128/aac.37.4.810 BindingDB Entry DOI: 10.7270/Q2KH0KHT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260669 (US9533985, 57) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0600 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260666 (US9533985, 54) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0770 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260683 (US9533985, 71) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0980 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260680 (US9533985, 68) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.130 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260671 (US9533985, 59) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.170 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260681 (US9533985, 69) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.210 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260660 (US9533985, 48) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.240 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260653 (US9533985, 41) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.260 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260654 (US9533985, 42) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.270 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260667 (US9533985, 55) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.270 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260689 (US9533985, 77) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.270 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260659 (US9533985, 47) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260662 (US9533985, 50) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260687 (US9533985, 75) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.380 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260686 (US9533985, 74) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260682 (US9533985, 70) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.410 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260661 (US9533985, 49) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.430 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260673 (US9533985, 61) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.460 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260679 (US9533985, 67) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260677 (US9533985, 65) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.560 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260656 (US9533985, 44) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.620 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260674 (US9533985, 62) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260683 (US9533985, 71) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.720 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM65394 (US9533985, 159 | US9533985, 40) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.730 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260690 (US9533985, 78) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.790 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260675 (US9533985, 63) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260651 (US9533985, 39) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.830 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260655 (US9533985, 43) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260685 (US9533985, 73) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.950 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM65383 (BDBM260657 | US9533985, 157) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.970 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260670 (US9533985, 58) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260658 (US9533985, 46) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260672 (US9533985, 60) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260681 (US9533985, 69) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260669 (US9533985, 57) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260684 (US9533985, 72) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260678 (US9533985, 66) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260666 (US9533985, 54) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260676 (US9533985, 64) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260668 (US9533985, 56) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260688 (US9533985, 76) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM65398 (BDBM260664 | US9533985, 177) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Gag-Pol polyprotein [588-1027]/[588-1147] (Human immunodeficiency virus type 1) | BDBM1434 (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | MMDB PDB Article PubMed | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 12: 6171-82 (2004) Article DOI: 10.1016/j.bmc.2004.08.050 BindingDB Entry DOI: 10.7270/Q23R0R24 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM65399 (US9533985, 178 | US9533985, 53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C] (Human immunodeficiency virus type 1) | BDBM2483 ((4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluor...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | MMDB PDB Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 13: 949-61 (2005) Article DOI: 10.1016/j.bmc.2004.11.045 BindingDB Entry DOI: 10.7270/Q2C53J1Z | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C] (Human immunodeficiency virus type 1) | BDBM2483 ((4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluor...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | MMDB PDB Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 12: 6171-82 (2004) Article DOI: 10.1016/j.bmc.2004.08.050 BindingDB Entry DOI: 10.7270/Q23R0R24 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Integrin alpha-4/Integrin beta-7/Mucosal addressin cell adhesion molecule 1 (Mus musculus (Mouse)-Homo sapiens (Human)) | BDBM260671 (US9533985, 59) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | 9.6 | 4 |
EA Pharma Co., Ltd. US Patent | Assay Description The ability of test substances to inhibit the binding of a human B cell line, RPMI-8866, which is known to express α4β7 integrin, to MAdCA... | US Patent US9533985 (2017) BindingDB Entry DOI: 10.7270/Q20C4TQ8 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 343 total ) | Next | Last >> |